GSK3882347
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GSK3882347, covering 2023-02-17 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections [Phase 1]